Kuwait orders nuclear emergency pills

MOORESVILLE, N.C., Jan. 23 (UPI) -- The government of Kuwait has contracted Internet-based radiation emergency products suppler Nukepills.com for a citizen protection initiative.

U.S. company Nukepills.com was awarded the contract from the Kuwaiti Ministry of Health. Under the approximately $1.4 million deal, Nukepills.com will supply 5.4 million of its trademarked ThyroShield potassium iodide doses.

Kuwait awarded the contract for the ThyroShield doses as part of an effort to stockpile nuclear radiation emergency protections. Officials say the ThyroShield is a liquid medicine that has thyroid-blocking capabilities to prevent thyroid cancer during radiation emergencies.

"This sale is the first large-scale order of ThyroShield from a foreign government," Troy Jones, Nukepills.com president, said in a statement.

"We are currently working on additional potassium iodide orders from other countries in the Middle East, Europe and Asia. We hope the new U.S. administration follows Kuwait's lead and reinstitutes the potassium iodide distribution plan to protect its citizens."